Literature DB >> 26809207

[The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma].

G Kristiansen1, L Egevad2, M Amin3, B Delahunt4, J R Srigley5, P A Humphrey6, J I Epstein7.   

Abstract

In 2005 the International Society of Urological Pathology (ISUP) held a concensus conference on Gleason grading in order to bring this grading system up to the current state of contemporary practice; however, it became clear that further modifications on the grading of prostatic carcinoma were necessary. The International Society of Urological Pathology therefore held a further consensus conference in 2014 to clarify these points. This article presents the essential results of the Chicago grading meeting.

Entities:  

Keywords:  Cribriform glands; Glomeruloid glands; Grouping systems; Intraductal carcinoma; Mucinous adenocarcinoma

Mesh：

Year:  2016        PMID： 26809207     DOI： 10.1007/s00292-015-0136-6

Source DB:  PubMed          Journal:  Pathologe        ISSN： 0172-8113            Impact factor:   1.011


  59 in total

1.  The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens.

Authors:  Burkhard Helpap; Lars Egevad
Journal:  Virchows Arch       Date:  2006-11-08       Impact factor: 4.064

2.  A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy.

Authors:  Zachary S Zumsteg; Daniel E Spratt; Isaac Pei; Zhigang Zhang; Yoshiya Yamada; Marisa Kollmeier; Michael J Zelefsky
Journal:  Eur Urol       Date:  2013-03-23       Impact factor: 20.096

3.  Survival rates of patients with prostatic cancer, tumor stage, and differentiation--preliminary report.

Authors:  J C Bailar; G T Mellinger; D F Gleason
Journal:  Cancer Chemother Rep       Date:  1966-03

4.  The association of the cribriform pattern with outcome for prostatic adenocarcinomas.

Authors:  G Kir; B C Sarbay; E Gümüş; C S Topal
Journal:  Pathol Res Pract       Date:  2014-06-19       Impact factor: 3.250

5.  Influence of pretreatment and treatment factors on intermediate to long-term outcome after prostate brachytherapy.

Authors:  Nelson N Stone; Mariana M Stone; Barry S Rosenstein; Pam Unger; Richard G Stock
Journal:  J Urol       Date:  2010-12-17       Impact factor: 7.450

6.  Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy.

Authors:  T Y Chan; A W Partin; P C Walsh; J I Epstein
Journal:  Urology       Date:  2000-11-01       Impact factor: 2.649

Review 7.  The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.

Authors:  Jonathan I Epstein; Lars Egevad; Mahul B Amin; Brett Delahunt; John R Srigley; Peter A Humphrey
Journal:  Am J Surg Pathol       Date:  2016-02       Impact factor: 6.394

8.  Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapy.

Authors:  Gregory S Merrick; Wayne M Butler; Robert W Galbreath; Jonathan H Lief; Edward Adamovich
Journal:  Urology       Date:  2002-07       Impact factor: 2.649

9.  Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

Authors:  Jennifer R Stark; Sven Perner; Meir J Stampfer; Jennifer A Sinnott; Stephen Finn; Anna S Eisenstein; Jing Ma; Michelangelo Fiorentino; Tobias Kurth; Massimo Loda; Edward L Giovannucci; Mark A Rubin; Lorelei A Mucci
Journal:  J Clin Oncol       Date:  2009-05-11       Impact factor: 44.544

10.  Prognosis of mucinous adenocarcinoma of the prostate treated by radical prostatectomy: a study of 47 cases.

Authors:  Adeboye O Osunkoya; Matthew E Nielsen; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2008-03       Impact factor: 6.394
View more
  5 in total

Review 1.  [Grading of prostate cancer].

Authors:  G Kristiansen; W Roth; B Helpap
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

Review 2.  [The long journey from palpation to biopsy : The history of diagnosing prostate cancer].

Authors:  J Konert; L Sentker; C August; M Hatzinger
Journal:  Urologe A       Date:  2021-07       Impact factor: 0.639

3.  Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT).

Authors:  Gregor Habl; Christoph Straube; Kilian Schiller; Marciana Nona Duma; Markus Oechsner; Kerstin A Kessel; Matthias Eiber; Markus Schwaiger; Hubert Kübler; Jürgen E Gschwend; Stephanie E Combs
Journal:  BMC Cancer       Date:  2017-05-22       Impact factor: 4.430

4.  CD147 and Prostate Cancer: A Systematic Review and Meta-Analysis.

Authors:  Fei Peng; Hui Li; Zhaoze Ning; Zhenyu Yang; Hongru Li; Yonggang Wang; Fang Chen; Yi Wu
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

5.  Proteomic Characterization of Prostate Cancer to Distinguish Nonmetastasizing and Metastasizing Primary Tumors and Lymph Node Metastases.

Authors:  Ann-Kathrin Müller; Melanie Föll; Bianca Heckelmann; Selina Kiefer; Martin Werner; Oliver Schilling; Martin L Biniossek; Cordula Annette Jilg; Vanessa Drendel
Journal:  Neoplasia       Date:  2017-12-14       Impact factor: 5.715
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.